Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Take your Pic
Top 10 Global Biopharmaceutical Companies in 2020
https://www.pharmaceutical-technology.com/features/top-ten-pharma-companies-in-2020/
https://www.sciencetimes.com/articles/26440/20200713/biopharmaceutical-companies.htm
I am beginning to form the opinion that Global Co are not Lilly and that at one point we had two parties being referred to as Globalco so he was allowed to name Lilly to avoid confusion. Lilly wouldn't be traditionally known as a bio-pharma company. I suspect that maybe JHFH was right when he suggested it was Pfizer.
Who knows, can only be one of a few?
I am beginning to think that we had two parties being referred to as Globalco. Vlad has allowed to identify one as Lilly to avoid confusion or we have had another globalco come on board since. Lilly wouldn't be traditionally know as a bio-pharmaceutical company. Maybe JHFH was correct when he suggested it was Pfizer. Who knows, can only be one of a few?
The more I learn about CLN's, the more obvious it becomes that we need some significantly positive news asap or we need to get rid of Mint. This current situation is not going to hold.
Exactly;those big sells are imho Mint converting
Is this now becoming a battle between private investors vrs MINT so enable the share price return to a fair value?
That's quite a battle if so and we may need a big investor to assist i feel
JHFH also said there was only on 'Globalco.'
I'm somewhat confused about MInt converting as they have to do so at not a great margin to the SP. Past conversions have been at a figure much higher than the SP today. It forces them to shift the converted shares quickly unless they see considerable upside in the longer term.
Well Vlad said he was pursuing other forms of finance and he did do that investor presentation a while back.
Maybe TMS will help... I'm sure that's part of their role.
Think they get a 10% discount to 7 day average SP;if that's the case ;they're notvdoing too bad now
Rick, they are forward selling the shares so Mint themselves don't have to believe their will be considerable upside. They are making their money now. They can't really lose out. If the SP falls, they get more shares, if the SP rises, they get a better forward selling price and more commission. If Hemo go bankrupt, Mint will get paid before we do. That's why this type of financing is cheap, it is high risk and often chosen by companies who have no other choice. Read up about it. I wish I had months ago. Lesson learned.
@B1ll and The-Hat, I thought it was Pfizer but the Lupus RNS states its the same global co and that has been named as Eli Lilly, so whilst I would love to have been right I can only accept the RNS is correct. In terms of the interview Vlad states that revealing the reason why GlobalCo dont want to licence now would reveal them and its a business reason clearly points still to Eli who yesterday had their early authorisation for their Covid antibody pulled. They will be smarting and want to make very sure any new product works before putting their name to it, paying top dollar is worth it to them to protect their image, especially right now. So odds on, Global Co is still Eli Lilly.
@Rickmeister, Very likely they saw the last RNS, same as many investors panicked and shaite the bed and started dumping out of fear of being locked in if the SP tanked below 1p. That interview has reassured investors but probably also Mint who will likely now wait and return to a more orderly selling in future which does not hurt the SP quite so much.
@MrIndia, yes your right, if people buy more than the £950k they converted then SP goes up, if they sell more than investors buy the SP dips, it is a battle. They tend to be selling in £5k, £10k blocks, rough numbers to make it look like random sells but in batches. I have not really tracked it but you could potentially allocate around £200k a day worth of sells to them and this is day 5 since the transfer sale we saw so if volume continues as it has been then they should be cleared either today or certainly this week. That clearing of the overhang would allow the SP to recover quickly.
If we bounce significantly then one of 2 things happen:
Next month when they convert, IF they convert, they once again stagnate the SP selling into rises until they clear another approx £900k of shares, but its not in their interest to crash, converting, SP rises, then sell benifits them much more.
Vlad is able to secure the financial stability of the company and repay the CLNs before more conversions.
I think we will be talking about the crash of '21 for a long time to come, it was extreme but hopefully we will recover now. I for one was almost convinced that Mint was planning a hostile takeover there for a while so I am almost relieved to see them churning the shares at this point!
The price used for the conversion (the "Conversion Price") will be equal to a 10 per cent. discount to the lesser of (i) 125 per cent. of the closing-bid price as reported by Bloomberg for one Ordinary Share one trading day before the relevant Issue Date (subject to adjustment to reflect any sub-division or consolidation of the Ordinary Shares) and (ii) the lowest closing bid-price as reported by Bloomberg for an Ordinary Share from the three consecutive trading days ending on the day prior to the date of service of the relevant conversion notice (or if such conversion notice is served after 4.35pm on any such date, then the three consecutive trading days ending on the day such conversion notice is served. In no event shall the Conversion Price be less than the nominal value of an Ordinary Share.
Final point @SSccss I may be wrong, maybe experts in this field can answer, but I dont believe Mint are forward selling, that is shorting and as a financial institution that level of forward selling would legally have to be declared. Up to this last conversion they have converted a batch of CLNs, Sp has recovered and they have slowly sold the shares over the month. This last conversion was special, they sold alot the first day in a bounce for a big profit, but then the SP kept crashing, you can only presume they were happy to take a loss given profits from day one and fear of going sub 1p if they did not.
Maybe JHFH, my understanding at the moment was that they are forward selling but I will do more research.
Thank you so much for your feedback ... it's gonna take a lot of big buying to get this back to even 7pence looks like ...
PS is this look like a conversion ... 21-Apr-21 13:53:13 3.745 277,714 Sell* 3.70 3.85 10.40k
As they seem to happen regularly throughout the day so when it looks like the share price is going up and then down !!!
Mint have 9 millions share s conversion so they will forward selling a lot . Hemo took their money and use shares as mortgage . nothing strange in here .we are all after money and Mint is the same .there is only stop if somehow Hemo have source money pay them back with 10 % interest and cut off CLN , no more share conversion or if there is nothing to pay back they will take back there money on shares sell it to open market..
As soon as some positive news or some how final get Hemo pay off we will fly but not now. Hemo will use money to do the work . nothing change in its course and the selling is continuing.
Thanks all for the replies re conversion. And nice to see blue today albeit diminishing.
yes shame ... was up nearly 10% percent and now only 4% and losing steam. Gonna be a long road to recovery
Previous two conversions were forward sold as the same number of shares were visible on LSE the same evenings that the RNSs containing the conversion announcements were released. Don't know about the latest
Since yesterday, sp up about 10%
Ssccss, not sure you really picked up on the point I was trying to make at 10.11 this morning (perhaps that's my fault), gauged by your response at 10.40. The science is pretty much done and I was primarily pointing out that in settling nerves during this difficult week, like MYLucy eluded to, reviewing their own research and that this was sufficient to stabilize their hypothesis at least, that this company was worth their continued faith and investment, despite what has "leathered" the share price. Mr Sandler can do nothing about Mint right now, BUT it was clear from his statement this morning that he understands the issue it is causing. If he cannot solve that difficulty then we certainly can't. Therefore, I think this is the reason likeminded investors have reviewed their own research, focussed their mind on the science not Mint and have settled down for the slightly longer journey none of us wanted. Bearing in mind that some investors on here have been on the train long before others. There was some criticism of Mr Sandler and his management but I think he grasps the issues raised by investors over the last week. He is not a one-man band and he has these products in reliable hands, in particular, HEMO CAR-T, with Randall Tlachac via Quality Systems who are far more than just science. We should all have confidence that this product will make good progress. In summary, satisfy yourselves that the core products have legs, are in the right hands and will give you a return on your investment and accept the things you cannot change right now ie MINT. (or go crazy!) Patience has been mentioned loads by many (mostly the one's who have been on the journey longer I reckon) - I think that was the message from this morning's presentation too. Sincerely GLA!
Yes Chris, I myself have been here 2 years. I understand patience is needed in terms of product development, clinical trials and realising value. However, I'm concerned Hemo might not get there as badly structured CLN's can backfire and put a company out of business in some scenarios.
I do understand your concerns Ssccss but not sure how those fears are allayed other than selling up. I think the product portfolio is there and sometimes it's simply down to gut instinct and fortune favouring the brave! Mr Sandler doesn't look as though he's losing much sleep over it. I wish you well with your strategy.
I hope there's a buffet car on this train! GLA